Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Application

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 15 > >>
EC Number Application Commentary Reference
Show all pathways known for 1.13.11.34Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.34drug development 5-lipoxygenase (5-LOX) is a target for drug design. Due to its role in the production of inflammatory lipid mediators, 5-LOX is a target for the development of therapeutics for conditions as diverse as asthma, cardiovascular disease, pancreatic cancer, and traumatic brain injury 741918
Show all pathways known for 1.13.11.34Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.34drug development caffeoyl clusters are good lead compounds in the design and synthesis of more potent 5-lipoxygenase inhibitors 702553
Show all pathways known for 1.13.11.34Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.34drug development due to their high potency against 5-lipoxygenase and the marked efficacy in biological systems, benzo[g]indole-3-carboxylates may have potential as anti-inflammatory therapeutics 705037
Show all pathways known for 1.13.11.34Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.34drug development gender difference in biosynthesis of leukotrienes (inflammatory mediators) may lead to new possibilities regarding development and use of 5-lipoxygenase inhibitors 704997
Show all pathways known for 1.13.11.34Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.34drug development human 5-lipoxygenase is a well-validated target for anti-inflammatory therapy. Development of 5-LOX inhibitors with higher activities is highly required 742067
Show all pathways known for 1.13.11.34Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.34drug development pirinixic acid derivatives constitute a novel class of dual mPGES-1/5-lipoxygenase inhibitors with a promising pharmacologial profile and a potential for therapeutic use 693577
Show all pathways known for 1.13.11.34Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.34drug development the enzyme is a target in drug design for cancer therapy, inhibitors inclinical trials, overview 686278
Show all pathways known for 1.13.11.34Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.34drug development the enzyme is an emerging target in obesity, insulin resistance, and artherosclerosis -, 688231
Show all pathways known for 1.13.11.34Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.34medicine direct 5-LO inhibitors are able to suppress the viability of various human tumour cells independently of 5-LO inhibition 711633
Show all pathways known for 1.13.11.34Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.34medicine powerful inhibitory properties of anthocyanins (delphinidin glycosides) towards lipoxygenases in relation to their currently known availability in human metabolism may in vivo prevent inflammatory diseases 705797
Results 1 - 10 of 15 > >>